Human
chondrosarcoma cells were stretched to 8 % strain at a frequency of 1 Hz.
In this study, we investigated the phosphorylation events in human
chondrosarcoma cells during cellular stretching.
In conclusion, the proteomic approach revealed that cellular stretching induced specific phosphorylation changes in
chondrosarcoma cells.
Rho - kinase inhibitor Y - 27632 and hypoxia synergistically enhance chondrocytic phenotype and change the S100 protein profile in human
chondrosarcoma cells
Not exact matches
The results showed that, when applied, a long - term inhibition of Rho - kinase signaling increased the expressions of chondrocyte - specific genes and differentiation markers in human
chondrosarcoma 2/8
cells.
Human
chondrosarcoma HCS - 2 / 8
cells, which are a type of benign bone cancer
cells, can be used to investigate how optimization of culture conditions could improve the synthesis of cartilage - specific molecules.»
Brien diagnosed Lovett with a tumor called clear
cell chondrosarcoma, an uncommon form of bone cancer that rarely responds to chemotherapy or radiation.
This thesis primarily investigates the effects of mechanical cyclic stretching, a 5 % low oxygen atmosphere and the Rho - kinase inhibitor, Y - 27632, on protein responses in chondrocytic human
chondrosarcoma (HCS - 2 / 8)
cells.
When their tumor
cells don't make osteoid and exclusively make cartilage, they have a condition that's referred to as
chondrosarcoma.
Approximately two - thirds of all canine nasal tumors are carcinomas, including adenocarcinoma, squamous
cell carcinoma and undifferentiated carcinoma; and one - third sarcomas, including fibrosarcoma,
chondrosarcoma, osteosarcoma, and undifferentiated sarcoma.
Other primary bone tumors include
chondrosarcoma, hemangiosarcoma, fibrosarcoma, lymphoma and plasma
cell tumors.
Other types of bone cancers include synovial
cell sarcoma, hemangiosarcoma,
chondrosarcoma and fibrosarcoma.